FDA PMA
FDA Class 3
Approved
🇺🇸 United States
Cardiac Ablation Percutaneous Catheter
PMA: P020045
·
Supplement: S099
·
Decision Aug 22, 2021
Classifications
1
FEI Numbers
52
Registration Numbers
52
Basic Information
- Device Name
- Cardiac Ablation Percutaneous Catheter
- Trade Name
- Freezor Xtra Cardiac Cryoablation Catheter
- PMA Number
- P020045
- Supplement Number
- S099
- Device Class
- FDA Class 3
- Product Code
- LPB
- Generic Name
- Cardiac ablation percutaneous catheter
- Medical Specialty
- Unknown
- Advisory Committee
- Cardiovascular
- Decision
- Approved
- Decision Code
- APPR
- Decision Date
- August 22, 2021
- Date Received
- July 19, 2021
- Supplement Type
- Real-Time Process
- Supplement Reason
- Change Design/Components/Specifications/Material
- Expedited Review
- N
Advisory Committee Statement
Approval for a software change to the CryoConsole system, primarily to enable the CryoMapping Mode for the Freezor Xtra Cardiac Cryoablation Catheter.
Classifications
This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.
| Product Code | Device Name | Device Class | Medical Specialty |
|---|---|---|---|
| LPB | Cardiac Ablation Percutaneous Catheter | FDA class 3 | Unknown |